|
CN111748631A
|
|
Characteristic miRNA expression profile combination and liver cancer early stage prediction method
|
|
CN111733252A
|
|
Characteristic miRNA expression profile combination and early gastric cancer prediction method
|
|
CN111718996A
|
|
Characteristic lincRNA expression profile combination and early gastric cancer prediction method
|
|
CN111748632A
|
|
Characteristic lincRNA expression profile combination and liver cancer early prediction method
|
|
CN111748634A
|
|
Characteristic lincRNA expression profile combination and early prediction method of colon cancer
|
|
CN111748633A
|
|
Characteristic miRNA expression profile combination and head and neck squamous cell carcinoma early prediction method
|
|
CN111718997A
|
|
Characteristic mRNA expression profile combination and early gastric cancer prediction method
|
|
CN111763738A
|
|
Characteristic mRNA expression profile combination and liver cancer early prediction method
|
|
CN111983236A
|
|
Gamma interferon release method for detecting SARS-COV-2 infection of novel coronavirus
|
|
CN111496835A
|
|
Inner skeleton bionic finger and bionic manipulator
|
|
CN111515936A
|
|
Exoskeleton bionic finger and bionic manipulator
|
|
CN111537463A
|
|
Method for quantitatively detecting uric acid in serum
|
|
CN111551736A
|
|
Ovarian hyperstimulation syndrome diagnostic marker Kallistatin and application thereof
|
|
CN111273460A
|
|
Glasses leg, glasses frame and goggles
|
|
CN111312359A
|
|
Intelligent recommendation method and device for medication scheme
|
